GLOBAL EPILEPSY MONITORING DEVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Developments

• On February 29, 2024, Empatica Inc., a healthcare company, launched EpiMonitor, an epilepsy monitoring system for adults and children aged 6 and above. EpiMonitor is an advanced wearable technology that is designed to detect generalized tonic-clonic seizures with high accuracy.
• In October 2022, Neuraxpharm, a global healthcare company, announced that it had signed a commercialisation agreement for mjn-SERAS, a wearable medical device that aims to predict the risk of having an epileptic seizure, with mjn-neuro., a manufacturer of medical devices with the aim of improving people's quality of life. With this agreement, Neuraxpharm increases its end-to-end offering for patients with epilepsy and enters the beyond-the-pill solutions market.
• In September 2021, The National Institutes of Health awarded a US$ 12.25 million grant to the University of California San Diego to develop and enhance brain-sensing and brain-stimulating platform technologies to enable treatment of drug-resistant epilepsy